Literature DB >> 21724448

Impact of image-guided radiotherapy to reduce laryngeal edema following treatment for non-laryngeal and non-hypopharyngeal head and neck cancers.

Nam P Nguyen1, Dave Abraham, Anand Desai, Michael Betz, Rick Davis, Thomas Sroka, Alexander Chi, Steven Gelumbauskas, Misty Ceizyk, Lexie Smith-Raymond, Michelle Stevie, Siyoung Jang, Russ Hamilton, Vincent Vinh-Hung.   

Abstract

We would like to determine the effectiveness of image-guided radiotherapy (IGRT) to reduce laryngeal edema following treatment for head and neck cancer and to assess patient perception of voice and speech after treatment. We conducted a retrospective review of 44 patients undergoing radiation for non-laryngeal and non-hypopharyngeal head and neck cancers. Endoscopic and/or mirror examinations of the larynx were performed following radiotherapy at each follow-up visit. Laryngeal edema was assessed based on the Radiation Therapy Oncology Group grading scale. Patients were also asked to rate about the voice and speech quality relative to their pre-radiotherapy status. The mean laryngeal dose was 16.3 Gy (range: 11.7-45.5 Gy). At a median follow-up of 14 months (range: 2-31 months), three patients (7%) developed laryngeal edema (one grade 1, two grade 2). The mean laryngeal dose was respectively 20.3 Gy in two patients and 20.7 Gy in the third patient developing laryngeal edema. Except for one patient who continued to smoke and drink after radiotherapy, no patient reported any significant change in voice and speech quality after treatment. IGRT results in low rates and low severity of laryngeal edema following treatment for non-laryngeal and non-hypopharyngeal head and neck cancers and may preserve voice quality.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21724448     DOI: 10.1016/j.oraloncology.2011.06.004

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  6 in total

1.  Omitting the lower neck and sparing the glottic larynx in node-negative nasopharyngeal carcinoma was safe and feasible, and improved patient-reported voice outcomes.

Authors:  F Xiao; S Dou; Y Li; W Qian; F Liang; L Kong; X Wang; K Wu; C Hu; G Zhu
Journal:  Clin Transl Oncol       Date:  2018-12-04       Impact factor: 3.405

2.  Prospective clinical study on long-term swallowing function and voice quality in advanced head and neck cancer patients treated with concurrent chemoradiotherapy and preventive swallowing exercises.

Authors:  Sophie A C Kraaijenga; Lisette van der Molen; Irene Jacobi; Olga Hamming-Vrieze; Frans J M Hilgers; Michiel W M van den Brekel
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-11-08       Impact factor: 2.503

3.  Impact of intensity-modulated and image-guided radiotherapy on elderly patients undergoing chemoradiation for locally advanced head and neck cancer.

Authors:  N P Nguyen; J Vock; A Chi; V Vinh-Hung; S Dutta; L Ewell; S Jang; M Betz; F Almeida; M Miller; R Davis; T Sroka; R P Vo; U Karlsson; P Vos
Journal:  Strahlenther Onkol       Date:  2012-06-03       Impact factor: 3.621

4.  Voice outcomes in patients with advanced laryngeal and hypopharyngeal cancer treated with chemo-radiotherapy.

Authors:  César Álvarez-Marcos; Andrea Vicente-Benito; Águeda Gayol-Fernández; Daniel Pedregal-Mallo; Paloma Sirgo-Rodríguez; Liliana Santamarina-Rabanal; José Luis Llorente; Fernando López; Juan Pablo Rodrigo
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-06       Impact factor: 2.618

5.  Feasibility of Tomotherapy-based image-guided radiotherapy to reduce aspiration risk in patients with non-laryngeal and non-pharyngeal head and neck cancer.

Authors:  Nam P Nguyen; Lexie Smith-Raymond; Vincent Vinh-Hung; Paul Vos; Rick Davis; Anand Desai; Thomas Sroka; Dave Abraham; Shane P Krafft; Michelle Stevie; Homayoun Modarresifar; Beng-Hoey Jo; Misty Ceizyk
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

6.  Image-guided radiotherapy for locally advanced head and neck cancer.

Authors:  Nam P Nguyen; Sarah Kratz; Claire Lemanski; Jacqueline Vock; Vincent Vinh-Hung; Alexander Chi; Fabio Almeida; Michael Betz; Rihan Khan; Juan Godinez; Ulf Karlsson; Fred Ampil
Journal:  Front Oncol       Date:  2013-07-08       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.